MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
Background: Metabolic side effects associated with atypical antipsychotics represent a major challenge in the clinical management of schizophrenia, contributing to poor treatment adherence and an increased risk of relapse. MicroRNAs (miRNAs) have emerged as promising diagnostic biomarkers for schizo...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2026-03-01
|
| シリーズ: | Therapeutic Advances in Psychopharmacology |
| オンライン･アクセス: | https://doi.org/10.1177/20451253261430603 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|